PETMED EXPRESS, INC. Acquisitions, Net of Cash Acquired
PETMED EXPRESS, INC. (PETS) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-06-02
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-03-31 was $0.00.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for fiscal 2026 was $0.00.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $35.86M.
- PETMED EXPRESS, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-K · filed 2026-06-02 | |||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $0.00 derived: sum of 2 quarters · filed 2026-06-02 | $0.00 derived: sum of 3 quarters · filed 2026-06-02 | $0.00 10-K · filed 2026-06-02 |
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $0.00 10-Q · filed 2025-02-10 | $0.00 derived: sum of 4 quarters · filed 2026-06-02 |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 3 quarters · filed 2026-06-02 | $0.00 derived: sum of 4 quarters · filed 2026-06-02 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 2 quarters · filed 2026-06-02 | $0.00 derived: sum of 3 quarters · filed 2026-06-02 | $0.00 derived: sum of 4 quarters · filed 2026-06-02 |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $0.00 derived: sum of 2 quarters · filed 2026-06-02 | $0.00 derived: sum of 3 quarters · filed 2026-06-02 | $35.86M 10-K · filed 2026-06-02 |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $0.00 derived: sum of 2 quarters · filed 2025-02-10 | $35.86M 10-Q · filed 2025-02-10 | $35.86M derived: sum of 4 quarters · filed 2025-10-14 |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $35.86M 10-Q · filed 2024-11-07 | $35.86M derived: sum of 3 quarters · filed 2025-10-14 | $35.86M derived: sum of 4 quarters · filed 2025-10-14 |
| 2023-06-30 | $35.86M 10-Q · filed 2024-08-07 | $35.86M derived: sum of 2 quarters · filed 2025-10-14 | $35.86M derived: sum of 3 quarters · filed 2025-10-14 | $35.86M derived: sum of 4 quarters · filed 2025-10-14 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-14 | $0.00 derived: sum of 2 quarters · filed 2025-10-14 | $0.00 derived: sum of 3 quarters · filed 2025-10-14 | $0.00 10-K · filed 2025-10-14 |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-04-15 | $0.00 derived: sum of 2 quarters · filed 2024-04-15 | $0.00 10-Q · filed 2024-04-15 | |
| 2022-09-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-04-15 | $0.00 10-Q/A · filed 2024-04-15 | ||
| 2022-06-30 | $0.00 10-Q/A · filed 2024-04-15 | |||
| 2022-03-31 | $0.00 10-K · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |